Vigil Neuroscience, Inc.
VIGL
$1.54
-$0.13-7.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.75% | 9.28% | -6.45% | 10.07% | -8.19% |
| Total Depreciation and Amortization | -0.88% | 0.88% | 0.00% | 0.00% | 2.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.31% | 2.57% | 13.45% | -28.26% | 55.81% |
| Change in Net Operating Assets | -85.74% | 576.70% | 171.90% | -224.53% | 220.09% |
| Cash from Operations | -521.79% | 127.74% | 29.15% | -41.08% | 10.42% |
| Capital Expenditure | -- | 100.00% | -- | -- | 72.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.22% | -1,680.36% | -93.63% | 54.35% | -30.55% |
| Cash from Investing | 147.22% | -1,687.93% | -93.66% | 54.54% | -30.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 8,598.04% | 466.67% | -99.83% | 9,681.13% | -3.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.66% | 220,577.78% | -99.83% | 9,681.13% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.49% | 152.49% | -6,154.98% | 95.19% | -146.64% |
